Abstract
A DNA segment of the MDV-1 BamHI-D fragment was sequenced, and the open reading frames (ORFs) present in the 4556 nucleotide fragment were analyzed by computer programs. Computer analysis identified 19 putative ORFs in the sequence ranging from a coding capacity of 37 amino acids (aa) (ORF-1a) to 684aa (ORF-1). The special properties of four ORFs (1a, 1, 2, and 3) were investigated. Two adjacent ORFs, ORF-1a and ORF-1, were found by computer analysis to have the properties of two introns encoding a glycoprotein: ORF-1a encodes an aa sequence with the properties of a signal peptide, and ORF-1 encodes a polypeptide with a membrane anchor domain and putative N-glycosylation sites in the aa sequence. ORF-1a and ORF-1 were found to be transcribed in MDV-1-infected cells. Two RNA transcripts were detected: a precursor RNA and its spliced form. Both are transcribed from a promoter located 5′ to ORF-1a, and splice donor and acceptor sites are used to splice the mRNA after cleavage of a 71-nucleotide sequence. This finding suggests that ORF-1a and ORF-1 are two introns of a new MDV-1 glycoprotein gene. The DNA sequence containing ORF-1 was transiently expressed in COS-1 cells, and the viral protein produced in these cells was found to react with anti-MDV serotype-1 Antigen B-specific monoclonal antibodies. These studies indicate that the protein encoded by ORF-1 has antigenic properties resembling Antigen B of MDV-1. A gene homologous to ORF-1 was detected in the genome of both MDV-2(SB1) and MDV-3(HVT), which serve as commercial vaccine strains. Two additional ORFs were noted in the 4556 nucleotide sequence: ORF-2, which encodes a 333 aa polypeptide initiating in the UL and terminating in the TRL prior to the putative origin of replication, and ORF-3, which encodes a 155 aa polypeptide that is partly homologous to the phosphoprotein pp38 encoded by the BamHI-H sequence. The 65 N-terminal aa of the two gene products are identical, both being derived from the nucleotide sequences in the TRL and IRL, respectively. Additional homologous aa sequences are the hydrophobic aa domain in the middle of both proteins. The functions of ORF-2, ORF-3, and additional ORFs are under study.
Similar content being viewed by others
References
Lee L.F., Kieff E.D., Bachenheimer S.L., Roizman B., Spear P.G., Burmester B.R., and Nazerian K., J Virol7 289–294, 1971.
Kaaden O.R., Scholz A., Ben-Zeev A., and Becker Y., Arch Virol54 75–83, 1977.
Fukuchi K., Sudo M., Lee Y., Tanaka A., and Nonoyama M., J Virol51 102–109, 1984.
Buckmaster A.E., Scott S.D., Sanderson M.J., Boursnell M.E.G., Ross N.L.J., and Binns M.M., J Gen Virol69 2033–2042, 1988.
Ross L.J.N., Sanderson M., Scott S.D., Binns M.M., Doel T., and Milne B., J Gen Virol70 1789–1804, 1989.
Bradley G., Hayashi M., Lancz G., Tanaka A., and Nonoyama M., J Virol63 2534–2542, 1989.
Fukuchi K., Tanaka A., Schierman L.W., Witter R.L., and Nonoyama M., Proc Natl Acad Sci USA82 751–754, 1985.
Maotani K., Kanamori A., Ikuta K., Ueda S., Kato S., and Hirai K., J Virol58 657–660, 1986.
Silva R.F. and Witter R.L., J Virol54 690–696, 1985.
Cui Z., Lee L.F., Liu J-L., and Kung H-J., J Virol65 6509–6515, 1991.
Cui Z., Yan D., and Lee L.F., Virus Genes3 309–322, 1990.
Chubb R.C. and Churchill A.E., Vet Rec83 4–7, 1968.
Isfort R.J., Kung H.-J., and Velicer L.F., J Virol61 2614–2620, 1987.
Ihara T., Kato A., Ueda S., Ishihama A., and Hirai K., Virus Genes3 127–140, 1989.
Coussens P.M. and Velicer L.F., J Virol62 2373–2379, 1988.
Coussens P.M., Wilson M.R., Camp H., Roehl H., Isfort R.J., and Velicer L.F., Virus Genes3 291–307, 1990.
Silva R.F. and Lee L.F., Virology136 307–320, 1984.
Davidson I., Becker Y., and Malkinson M., Arch Virol121 125–139, 1991.
Hirai K., Nakajima K., Ikuta K., Kirisawa R., Kawakami S., Mikami T., and Kato S., Arch Virol89 113–130, 1986.
Sithole I., Coussens P.M., Lee L.F., and Velicer L.F., inAdvances in Marek's Disease Research. Proceedings of the 3rd International Symposium on Marek's Disease, Osaka, Japan, 1988, pp. 148–155.
Yanagida N., Ogawa R., Li Y., Lee L.F., and Nazarian K., J Virol66 1402–1408, 1992.
Nazerian K., Lee L.F., Yanagida N., and Ogawa R., J Virol66 1409–1413, 1992.
Maray T., Ph.D. thesis, Hebrew University of Jerusalem, September 1989, submitted.
Moyal M., Asher Y., Darai H., Rosen-Wolff A., Vafai A., and Becker Y., Virus Genes5 133–146, 1991.
Davidson I., Malkinson M., and Becker Y., Virus Genes2 5–18, 1988.
Becker Y., Asher Y., Tabor E., Davidson I., Malkinson M., and Weisman Y., J Virol Methods40 307–321, 1992.
Witter R.L., Avian Dis31 752–765, 1987.
Becker Y., Asher Y., Tabor E., Davidson I., Malkinson M., and Witter R.L., Virus Genes7 277–287, 1993.
Sanger F., Nicklen S., and Coulson A.R., Proc Natl Acad Sci USA74 5463–5467, 1977.
Chirgwin J.M., Przybyla A.E., MacDonald R.J., and Rutter W.J., Biochemistry18 5294–5299, 1979.
Ben-Hur T., Moyal M., Rosen-Wolff A., Darai G., and Becker Y., Virology169 1–8, 1989.
Morgan R.W., Cantello J.L., and McDermott C.H., Avian Dis34 345–351, 1990.
Devereux J., Haeberli P., and Smithies O., Nucleic Acids Res12 387–395, 1984.
Wolf H., Modrow S., Motz M., Jameson B.A., Hermann G., and Fortsch B., CABIOS4 187–191, 1988.
Ross L.J.N., Binns M.M., Sanderson M., and Schat K.A., Virus Genes7 33–51, 1993.
Becker Y., Virus Genes5 287–312, 1991.
Malkinson, M., Davidson, I., and Becker Y., Arch Virol127 169–184, 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Becker, Y., Asher, Y., Tabor, E. et al. Open reading frames in a 4556 nucleotide sequence within MDV-1 BamHI-D DNA fragment: Evidence for splicing of mRNA from a new viral glycoprotein gene. Virus Genes 8, 55–69 (1994). https://doi.org/10.1007/BF01703602
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01703602